Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-042474

Chief Product Officer gave up 976 shares (to pay taxes)

  • Chief Product Officer acquired 3,324 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Besch Doug Chief Product Officer 2024-10-03 Option exercise +3,324 11,172 D
Besch Doug Chief Product Officer 2024-10-03 Shares withheld for taxes −976 $7.83 $7,642 10,196 D
Derivatives
Besch Doug Chief Product Officer 2024-10-03 Option exercise · Restricted Stock Units −3,324 3,325 D
Loading xslF345X05/wk-form4_1728350639.xml…